Elevated Siglec-7 expression correlates with adverse clinicopathological, immunological, and therapeutic response signatures in breast cancer patients
These findings strongly suggest a central role for Siglec-7 as a promising therapeutic target and prognostic biomarker for human breast cancer, warranting further investigation into its clinical potential.
Authors
- Ibtissam Rezouki
- Kenza Miyara
- H. Aschawa
- Abdallah Badou (ORCID: https://orcid.org/0000-0003-4849-9085)
- Oumayma Naji
- Basma Zohair
- Hamza Benthami
- Mohamed Elkarroumi
- Simohamed Ennachit
Institutions
- Centre Hospitalier Universitaire Ibn Rochd (MA)
- University of Hassan II Casablanca (MA)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-06-06
- DOI
- https://doi.org/10.3389/fimmu.2025.1573365
- Citations
- 4
- Primary Topic
- Oral Health Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.86